CD79A and nasopharyngeal carcinoma: The other five seromarkers (BLLF3-IgA, BLRF2-IgA, BLRF2-IgG, BDLF1-IgA, and BDLF1-IgG) had limited ability to identify NPC patients when used individually (Fig. 5, A and C, Table 1).